Announcements Trials
Browse Landscape

Phase

Phase 4 9Phase NA 4Phase 3 4Phase EARLY_PHASE1 2Phase 2 2Phase 1 2Phase 2/3 1

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 6Tumor-Agnostic 5Breast 5Other solid neoplasm 4Other hematologic neoplasm 4Genitourinary 4Lymphoid 3Gynecologic 3CNS 3Plasma cell 2Other 2Head & Neck 2Dermatologic 2Thoracic 1Sarcoma 1Classical hematology 1

Conditions

Obesity 2Polycystic Ovary Syndrome 1Lipid Metabolism Disorders 1Diabetes Mellitus 1Cardiovascular Diseases 1Breast Neoplasms 1

Interventions

Metformin 2rosiglitazone-metformin combination 1mirabegron 1lorcaserin 1exemestane 1atezolizumab 1angiotensin I (1-7) 1Traumeel S 1Tirzepatide 1TIC10 compound 1Sodium Chloride 1Rosiglitazone 1Radiotherapy, Intensity-Modulated 1Radiotherapy 1Melphalan 1Leflunomide 1Hydroquinones 1Fish Oils 1Fibroblast Growth Factor 7 1Drug Therapy 1Docosahexaenoic Acids 1Cisplatin 1Cholestyramine Resin 1CBLB502 1Ascorbic Acid 1Acupuncture Therapy 1ART123 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 1 × Metformin × Other × Clear all
NCT04116203 2025-02-28

PCOS

University of Alberta

Phase 1 Completed
52 enrolled
Other

Cardiovascular Diseases, Diabetes Mellitus, Obesity, Polycystic Ovary Syndrome, Lipid Metabolism Disorders

NCT00933309 2016-02-19

The Impact of Obesity and Obesity Treatments on Breast Cancer

M.D. Anderson Cancer Center

Phase 1 Completed
25 enrolled
BreastOther

Breast Neoplasms, Obesity

Data powered by HemOnc (CC BY 4.0) Colophon âš¡